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Role of actin-filament disassembly in lamellipodium protrusion
in motile cells revealed using the drug jasplakinolide
Louise P. Cramer
Background: In motile cells, protrusion of the lamellipodium (a type of cell
margin) requires assembly of actin monomers into actin filaments at the tip of
the lamellipodium. The importance of actin-filament disassembly in this process
is less well understood, and is assessed here using the actin drug
jasplakinolide, which has two known activities – inhibition of filament
disassembly and induction of an increase in actin polymer.
Results: In cells the two activities of jasplakinolide were found to be separable;
1 µM jasplakinolide could permeate cells, bind cellular filamentous actin
(F-actin) and inhibit filament disassembly within 3.5 minutes, but significant
increase in actin polymer was not detected until 60 minutes of treatment. In live,
permeabilised cells, jasplakinolide did not inhibit filament assembly from
supplied, purified actin monomers. In migrating chick fibroblasts, lamellipodium
protrusion was blocked within 1–5 minutes of treatment with 1 µM
jasplakinolide, without any perturbation of actin organisation. In non-migrating
chick fibroblasts, there was a delay in the onset of jasplakinolide-induced
inhibition of lamellipodium protrusion, during which lamellipodium length
increased linearly with no increase in protrusion rate. Motility of the bacterium
Listeria in infected PtK2 cells was reduced 2.3-fold within 3 minutes of
treatment with 1 µM jasplakinolide.
Conclusions: Actin-filament disassembly is tightly coupled to lamellipodium
protrusion in migrating chick fibroblasts and motility of Listeria in PtK2 cells.
One simple interpretation of these data is a situation whereby ongoing actin-
filament assembly uses free actin monomer derived from filament disassembly,
in preference to stored monomer.
Background
In motile cells, protrusion of the lamellipodium is
involved in wound healing and immune cell activation,
and is required for entry of certain pathogenic organisms
into cells. Protrusion motility is key to bringing the front
margin of a migrating cell forward. Protrusion of the lamel-
lipodium (and related structures such as filopodia) is
tightly coupled to assembly of actin monomers into actin
filaments at the cell margin [1,2]. Protrusion motility has
been studied over several decades or so [1–3], but the
focus of the work has been on actin-filament assembly and
regulation of assembly; filament disassembly has been
largely overlooked [2,4]. 
There must be a constant supply of actin monomers in the
region of the cell where a lamellipodium is persistently
protruding. Although filament disassembly maintains the
general monomer pool, it is not known whether there is a
direct link between filament disassembly and protrusion
motility. Part of the problem is that it has long been recog-
nised that almost the entire population of cellular actin
monomer is stored (not free for assembly) [5], most likely
by monomer-sequestering proteins [6] such as thymosin-
B4 [7]. If stored monomer is to be used for assembly, it
must first be freed from stores, but very little is known
about the spatial regulation of this process in the cell. This
makes it difficult to predict whether stored actin monomer
is generally used during protrusion, and thus difficult to
predict the importance of actin filament disassembly in
this process. It might turn out that the importance varies
in cells, depending on monomer availability. This seems
likely as the cellular concentration of actin monomer rela-
tive to filaments can vary with cell type and motile cell
behaviour. For these reasons, the link between actin fila-
ment disassembly and protrusion in cells was tested using
jasplakinolide, an inhibitor of actin-filament disassembly,
in several different motile cell systems: protrusion of the
lamellipodium in migrating cells and in non-migrating
cells, and motility of the bacterium Listeria monocytogenes
[8], a model system for protrusion [9,10] as motility of
L. monocytogenes is tightly coupled to actin-filament assem-
bly  [11,12]. The work also provides new information on
actin-assembly dynamics in cells, with implications for
regulation of protrusion motility. 
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A migrating cell is composed of distinct regions: the lamel-
lipodium is at the front of the cell; behind this is the
lamella, followed by the cell body, which comprises most
of the organelles and the nucleus; at the rear is a rounded
or drawn-out tail. The migration process, which results in
the entire cell translocating to a new position, comprises
protrusion of the lamellipodium, cell-body translocation
and tail retraction. Non-migrating cells can also be com-
posed of the same regions and be motile, but only protru-
sion motility typically occurs with no net cell translocation.
A further key difference is that a migrating cell is polarised
(typically wedge-shaped or crescent-shaped), with only a
single lamellipodium at the front of the cell which persis-
tently protrudes as the cell migrates. In contrast, a non-
migrating cell is not polarised (typically orthogonal in
shape) and might protrude several lamellipodia at multi-
ple sites around the cell and these tend to persist for
shorter periods than migrating cells. Here, lamellipodium
protrusion was studied in migrating and non-migrating
chick embryo heart fibroblasts, a well-characterised system
for investigating motility.
A natural product from a marine sponge [13,14], jasplaki-
nolide specifically targets actin, without affecting micro-
tubules [15], DNA, RNA or protein synthesis [16]. It is
similar to the well-known actin inhibitor phalloidin in that,
like phalloidin [17,18], jasplakinolide stabilises actin fila-
ments, preventing filament disassembly, both with puri-
fied actin [19] and in cells [20]. Like phalloidin [17],
jasplakinolide also causes an increase in actin polymer
with purified actin [19] and in cells [21,22]. The mecha-
nism underlying  this increase has not been reported for
jasplakinolide; one possible explanation is spontaneous
promotion of actin assembly. Any such activity is expected
to be comparatively weak in cells (M. Bubb, personal com-
munication). This is advantageous, allowing one to deter-
mine experimental conditions that favour inhibition of
filament disassembly without significant increase in actin
polymer. Jasplakinolide and phalloidin are the only known
inhibitors of actin-filament disassembly but, unlike phal-
loidin, jasplakinolide is cell-permeant, enabling the effects
of blocking actin disassembly in motile cells to be easily
studied. Previous work with jasplakinolide has not allowed
such an analysis because cells were treated under experi-
mental conditions that caused significant increase in actin
polymer and gross disruption of actin organisation. Here,
actin-filament disassembly was found to be tightly coupled
to protrusion of the lamellipodium during fibroblast migra-
tion and Listeria motility in PtK2 cells. 
Results
Jasplakinolide dose and actin-cytoskeleton organisation
At acute doses, all known actin and tubulin drugs cause
general perturbation to their respective cytoskeletons. To
allow interpretation of specific effects on cell motility, a
dose must first be identified at which general perturbation
does not occur. Treatment of migrating and non-migrating
chick fibroblasts with 1 µM jasplakinolide for up to
20 minutes, or PtK2 cells with the same dose for up to
15 minutes did not disrupt actin-cytoskeleton organisation
nor general cell morphology. Small changes started to
occur in 15–30% of fibroblasts at 20 minutes and in PtK2
cells at 15 minutes; small actin filament foci/aggregates
appeared, but otherwise the actin cytoskeleton was intact
(see below). By 60 minutes of treatment with 1 µM jas-
plakinolide, the actin cytoskeleton was generally perturbed;
large filament aggregates appeared in 100% of fibroblasts
and PtK2 cells, with no other actin organisation visible by
light microscopy (see below). As motility was studied over
a 10 second–1 minute time scale, any specific change in
motility could be readily assessed well in advance of
general perturbation to actin organisation. Higher doses
(5–20 µM) of jasplakinolide induced abnormal actin organ-
isation in 100% of cells by 10 minutes, and are therefore
less useful in this context.
Permeability of cells to jasplakinolide
A test based on competition between jasplakinolide and
phalloidin for binding to filamentous actin (F-actin) [19]
showed no detectable difference between fibroblasts and
PtK2 cells in terms of their permeability to jasplakinolide,
and ability of the drug to bind cellular F-actin in the two
cell types. Within 2.5 minutes of pretreating live intact
cells with 1 µM jasplakinolide, the intensity of
Alexa594–phalloidin staining (0.25 µg/ml) of actin fila-
ments in the tip of the lamellipodium in subsequently
fixed cells decreased by about one-third compared with
non-pretreated cells (decreasing by 35% ± 3% in migrating
fibroblasts, 33% ± 5% in non-migrating fibroblasts, and
38% ± 3% in PtK2 cells; average of 28–44 measurements in
20–40 cells). The lamellipodium tip was measured to avoid
any potential overestimation of fluorescence intensity in
jasplakinolide-treated cells where filament disassembly is
blocked; filament disassembly is thought to occur predomi-
nantly at the rear, not at the tip of the lamellipodium. A
similar decrease in fluorescence intensity was seen in Swiss
3T3 cells, a fibroblast cell line. Thus, it is probable that, in
cells in general, entry of jasplakinolide into cells and its
binding to cellular F-actin is rapid.
Assessment of jasplakinolide’s actin-filament-stabilising
and actin-filament-promoting activity
Jasplakinolide (0.55–2.2 µM) inhibits disassembly of pre-
formed actin filaments within 30 seconds of adding the
drug in a dilution assay in vitro (M. Bubb, personal com-
munication). In contrast, it takes tens of minutes for jas-
plakinolide to promote filament assembly in
non-polymerising buffer [19]. Similarly, for fibroblasts and
PtK2 cells, stabilisation of actin filaments by jasplakino-
lide was similarly rapid, but filament-promoting activity
comparatively slow. When live cells are briefly perme-
abilised in buffer without actin protection, lamellipodia
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are poorly preserved [23–25] (compare Figure 1b with
Figure 1c, and Figure 1f with Figure 1g). This is because
of dilution-induced disassembly of actin filaments in
lamellipodia. Actin filament bundles in the cell body,
having a slower turnover rate, remain intact during brief
permeabilisation. Addition of 1 µM jasplakinolide to the
permeabilisation buffer prevented filament disassembly
in lamellipodia (actin filaments remained intact) within
1 minute in all cell types tested (Figure 1a), as exempli-
fied by migrating fibroblasts (compare figure 1b with
figure 1e) and PtK2 cells (compare figure 1f with figure
1i). This effect was indistinguishable from actin protec-
tion provided by 1 µM phalloidin in the permeabilisation
buffer (compare figures 1d and 1h with figures 1e and 1i).
In intact cells, considering the above cell permeability
and stabilisation data, jasplakinolide is expected to inhibit
actin-filament disassembly within at most 3.5 (2.5 + 1)
minutes. That there was no detectable difference in three
different cell types suggests that inhibition is rapid in
cells in general. 
Filament-promoting activity in jasplakinolide-treated cells
was measured by immunofluorescence in subsequently
fixed fibroblasts and PtK2 cells (see the Materials and
methods section). Any increase in actin polymer induced
before cell fixation was indicated by an increase in fluores-
cence intensity. An increase in fluorescence intensity was
not detected until 60 minutes treatment with 1 µM jas-
plakinolide, increasing by 37% in migrating fibroblasts, by
25% in non-migrating fibroblasts, and by 43% in PtK2 cells
(average of 10–12 cells measured per cell system). This
increase was concomitant with the appearance of large fila-
ment aggregates in these cells at 60 minutes (see above
and examples below), possibly indicating spontaneous
polymer formation. Initiation of filament-promotion might
occur before 60 minutes, potentially reflected in the small
actin-filament foci that appeared in a small proportion of
cells after 15–20 minutes treatment (see above and
example below). Whether all aggregates reflect sponta-
neous polymer formation is unknown. It is plausible that
some aggregates form by coalescence of pre-existing actin
filaments and bundles, consistent with the absence of fila-
ment bundles (see below) around 60 minutes of treatment.
Testing direct inhibition of actin assembly by jasplakinolide
There are no data in the literature to suggest that jasplaki-
nolide directly blocks actin-filament assembly. In live
permeabilised fibroblasts, 1 µM jasplakinolide did not
inhibit cellular assembly of filaments from supplied
exogenous actin monomers (Figure 2). A mixed popula-
tion of migrating and non-migrating fibroblasts was tested
simultaneously (see the Materials and methods section)
and no difference in ability to incorporate actin in cells
was detected. Also, under the conditions used to study
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Figure 1
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Non-migrating fibroblasts
PtK2 cells
Migrating fibroblasts
Swiss 3T3 cells
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(b)
(d) (e)
(c) (f) (g)
(h) (i)
Fibroblasts
Not permeabilised Permeabilised Permeabilised
Permeabilisation
+ phalloidin
Permeabilisation
+ jasplakinolide
Permeabilisation
+ phalloidin 20 µm
Not permeabilised
Permeabilisation
+ jasplakinolide
Actin-filament stabilisation in cells. (a) Quantitation of intact
lamellipodia. Live migrating and non-migrating fibroblasts, PtK2 cells
and Swiss 3T3 cells were permeabilised for 1 min in the absence or
presence of 1 µM jasplakinolide or 1 µM unlabelled phalloidin, then
fixed and stained for actin filaments; 200 cells were counted in each
category. (b–e) Migrating fibroblasts and (f–i) PtK2 cells that have
been (b,f) pretreated live in permeabilisation buffer without detergent,
or permeabilised live (c,g) without jasplakinolide or phalloidin, or in the
presence of (d,h) phalloidin or (e,i) jasplakinolide. Lamellipodia are
denoted between pairs of arrowheads in (b,d,e,f,h,i). The lamellipodium
in (c) is not preserved and in (g, arrows) poorly preserved as
fragments. In contrast to Figure 2, the permeabilisation buffer did not
contain exogenous actin monomer; thus, lamellipodia are not protected
when permeabilised live in the absence of jasplakinolide or phalloidin.
motility, jasplakinolide (1 µM, up to 20 minutes) did not
alter known spatial differences in actin dynamics in cells;
most rapid actin dynamics occurred in the lamellipodium
(Figure 2e,f; yellow, arrow). In a second test using intact,
migrating and non-migrating fibroblasts cultured sepa-
rately, endogenous actin filaments in lamellipodia were
first selectively disassembled (actin filament bundles in
the cell body remaining intact) by gentle pretreatment
with latrunculin-A (5 µM, 5 minutes). Jasplakinolide
(1 µM) did not block reassembly of filaments and refor-
mation of lamellipodia when present during washout of
latrunculin-A (data not shown). This also shows that jas-
plakinolide neither sequesters actin monomer, blocks
nucleation of new filament formation, nor interferes with
spatial coupling between filament assembly and forward
movement of the cell margin.
Considering these data together, a conservative estimate
is that any change in behaviour when treating chick
fibroblasts for up to 20 minutes and PtK2 cells for up to
15 minutes with 1uM jasplakinolide specifically reflects
inhibition of actin-filament disassembly.
Jasplakinolide rapidly inhibits protrusion of the
lamellipodium in migrating fibroblasts
In individual migrating fibroblasts, 1 µM jasplakinolide
fully inhibited protrusion of the lamellipodium within
1–5 minutes (Figure 3d, vertical line; Figure 3e), but
translocation of the cell body remained constant
(Figure 3a–d,f). Inhibition of protrusion also occurred at
200–500 nM jasplakinolide, but was less effective at
100 nM (data not shown). In the cell population, inhibi-
tion of protrusion averaged 3–5 minutes (see below). Once
protrusion was inhibited, then over the next 5–10 minutes
of treatment, the lamellipodium typically stayed ‘frozen’
in place (Figure 3d, vertical line), or slightly retracted in
discrete zones. Also, once protrusion was inhibited, new
lamellipodia did not form at new cellular sites. By
20 minutes of treatment, the lamellipodium had typically
retracted, either completely or in larger discrete zones
(Figure 3c,d; diagonal dots). Because the cell body per-
sisted in moving forward during the entire course of jas-
plakinolide treatment (10–30 minutes for individual
experiments), it encroached on the cell margin (clearly
seen in Figure 3d). As expected, a similar effect occurs
when migrating keratocytes are treated in the short term
with cytochalasin [26]. 
Although cell-body translocation in migrating fibroblasts
persisted in jasplakinolide, there was an effect on the
direction of motility. In all jasplakinolide-treated cells,
the cell body continued to move forward (towards the
lamellipodium), as occurs normally during cell migration
but, in around 70% (14/20) of the cells, small portions of
the cell body lost coherence and broke away, moving
instead towards the rear (for example, Figure 3c, middle
cell between long arrow and arrowhead) or side of the
cell. One hypothesis is that ongoing protrusion simply
plays a role in maintaining coherent forward motion of the
cell body.
Inhibition of protrusion by 1 µM jasplakinolide was not
because of potential general disruption of the actin
cytoskeleton, nor general inactivation of actin-based
motility. At the time protrusion was inhibited
(1–5 minutes), cell morphology (clearly observed in the
movie published as Supplementary material with this
article on the internet, and in Figure 3b) and actin organi-
sation (compare Figure 4a with Figure 4b) were normal at
the level of resolution of the light microscope. Further
cell-body translocation in treated cells was not inhibited
(see above). Translocation of the cell body in these cells
is driven by myosin interacting with already assembled
actin filament bundles [27]. As these bundles remained
intact when translocation was occurring in the presence
of jasplakinolide (for example, Figure 4c, long arrow), sta-
bilisation of actin filaments by jasplakinolide per se does
not prevent actin-based motility. As a further control,
another type of myosin-driven cell motility, cell
respreading after mitosis in PtK2 cells [24,28], was also
not inhibited by 1 µM jasplakinolide (Table 1). Higher
concentrations of jasplakinolide (up to 2–3 µM), 15-times
higher than the lowest concentration that inhibits protru-
sion in fibroblasts, also did not inhibit cell respreading
after mitosis.
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Figure 2
Incorporation of exogenous actin monomer in cells. (a,c,e) Control
fibroblasts and (b,d,f) fibroblasts treated with 1 µM jasplakinolide were
permeabilised live for 10 min in the presence of 1 µM fluorescently
labelled exogenous actin monomer, then fixed and stained for total
F-actin. (a,b) Total cellular F-actin (red). (c,d) Exogenous actin
incorporated into cells (green). (e,f) Twofold magnification of the
merged images of (a,c) and (b,d), respectively. The exogenous actin
assembled into filaments is highest in lamellipodia (yellow or yellow-
green, arrow). The scale bar in (d) applies to (a–d), the scale bar in
(f) applies to (e,f).
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Effect of jasplakinolide on lamellipodium protrusion in
non-migrating fibroblasts
Although jasplakinolide started to inhibit protrusion in
migrating fibroblasts within 1–2 minutes (Figure 3e), the
onset of inhibition was delayed by about 10 minutes in
non-migrating fibroblasts (Figure 5a, filled symbols).
Protrusion rate then slowed down, with full inhibition
within 12–20 minutes in individual non-migrating fibrob-
lasts (Figure 5a, filled symbols; Figure 6, squares). This
difference was not simply because there is more F-actin
to stabilise in non-migrating cells; in untreated cells, F-
actin was 1.3-fold higher in lamellipodia, and 1.1-fold
higher in the rest of the cell, yet overall it took fourfold
longer to completely inhibit protrusion. Also, it was
neither because of a difference in the rate of protrusion
of the lamellipodium (Table 1, before treatment,
compare non-migrating with migrating cells), nor to
general disruption of the actin cytoskeleton when pro-
trusion is inhibited (compare Figure 5c and Figure 5d). 
In non-migrating fibroblasts, as was expected, when disas-
sembly, but not lamellipodium protrusion, was inhibited,
the lamellipodium increased in length (in the direction of
the protrusion). This was a specific effect and was not
because of an increase in protrusion rate; as mentioned
above, this increase did not occur. Increase in lamel-
lipodium length was readily detected (see Materials and
methods) in individual live cells from the time-lapse
record (Figure 5a, open symbols) and in fixed and stained
cells (Figure 5b; Figure 5f, compare upper and lower
images, between pairs of vertical lines). In live cells, the
length of a given lamellipodium was constant before jas-
plakinolide treatment, but increased linearly with time in
the presence of the drug (Figure 5a, open symbols). Each
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Figure 3
Jasplakinolide treatment of migrating
fibroblasts. Live migrating fibroblasts were
treated with 1 µM jasplakinolide and imaged
every minute by phase contrast time-lapse
microscopy. (a–c) The three pairs of outlines
indicate the position to which three migrating
cells had moved to after 4 min in
jasplakinolide (b). The outlines correspond to
the position of the margin of the lamellipodium
and front boundary of the cell body in (b). (a)
Control, 14 min before addition of
jasplakinolide. (b) After 4 min in jasplakinolide.
The lamellipodium did not protrude beyond
the longer outline from its position in
(a; arrowhead). In the left cell, protrusion
stopped by 1 min (see (d)), and in the other
cells by 3–4 min (see (e)). The cell body
moved from its position in (a; arrow) to the
shorter outline. (c) After 20 min in
jasplakinolide. The lamellipodium retracted
(gap between cell edge and longer outline).
The cell body continued moving forward from
its position in (b; from the shorter outline to
the short arrows). The overall appearance of
the cell body was less coherent. A cell-body
fragment moved to the rear cell margin
(middle cell; from the long arrow, which
indicates the position at 10 min in
jasplakinolide, to the arrowhead).
(d) Kymograph image (time–position plot)
along a line (0.7 µm wide) of the vector of
migration, perpendicular to the lamellipodium,
of the left cell in (a–c). The cell is migrating
towards the left. Cell position (horizontal axis)
on the line is shown every minute (vertical
axis) from 18 min before addition of
jasplakinolide (0 min, long arrow) to 22 min
after addition. The lamellipodium is uniform
grey density on the left (for example,
arrowhead). The cell body is a mixture of light
and dark phase density on the right (for
example, between the arrows). Diagonal solid
lines towards the left are examples of constant
forward motility. The vertical line indicates
inhibition of protrusion. Diagonal dots towards
the right indicate retraction of the
lamellipodium. (e,f) History of (e)
lamellipodium protrusion and (f) cell-body
translocation before and during jasplakinolide
treatment for the three migrating cells shown
in (a–c). The scale bar in (c) applies to (a–c).
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lamellipodium stopped increasing in length (Figure 5a,
open symbols, plateaus on the plots) concomitant with
inhibition of protrusion in the same cell (Figure 5a, filled
symbols, plateaus on the plots). As expected, when indi-
vidual lamellipodia in untreated cells were compared,
there was a range of lengths (Figure 5b, unshaded bars).
Thus, not unexpectedly, this also occurs in jasplakinolide-
treated cells, but the range was clearly shifted to longer
lengths (Figure 5b, compare unshaded and shaded bars).
Comparing lamellipodia at 10 and 20 minutes treatment,
the length distribution overlapped (Figure 5b, compare
shaded bars). This was highly consistent with inhibition of
protrusion (12–20 minutes, see above). By 20 minutes of
jasplakinolide treatment, lamellipodia had on average
increased 6.2-fold (7.3/1.1 µm) in length, an average
length increase of 6.2 µm, observed for both live and fixed
cells. This was reasonably close to the increase in length
(8.7 µm) estimated from the average rate of protrusion in
treated cells (Table 1). The difference is likely a conse-
quence of variation in the time it took for individual
lamellipodia to stop protruding. 
Also as expected, when actin-filament disassembly was
inhibited, filaments apparently accumulated towards the
back of the lamellipodium (Figure 5f, arrows). Such an
accumulation was not observed in untreated cells, and was
clearly distinct from dorsal actin ruffles which, in these
cells, are characteristically thin and wavy. Also in a small
proportion of cells slight promotion of filament assembly
(see above) might make a minor contribution to filament
accumulation. In migrating cells, jasplakinolide also
induced an increase in lamellipodium length by an
average 2.2 µm, before protrusion was blocked within 5
minutes. In contrast to non-migrating cells, an accumula-
tion of actin filaments was not detected at the rear of the
lamellipodium; presumably, comparatively little actin
accumulates before rapid inhibition of protrusion in
migrating cells. 
Effect of jasplakinolide on Listeria motility
The initial response of Listeria motility in jasplakinolide-
treated PtK2 cells was very similar to protrusion in migrat-
ing fibroblasts. For both systems, there was a rapid
decrease in the rate of motility, on average to less than one
half of the control by 3 minutes of treatment with jasplaki-
nolide (Figure 6, compare circles and diamonds; Table 1).
Longer exposure to jasplakinolide revealed a difference; it
took on average 3–5 minutes to completely inhibit protru-
sion in migrating fibroblasts, but 3–15 minutes to com-
pletely inhibit all Listeria motility (Figure 6, compare
circles and diamonds). It was not possible to determine
from the time-lapse record (phase-contrast images)
whether Listeria tails increased in length in treated cells, as
only the bacterium body was highly visible by this method.
Discussion
This study revealed that short-term treatment with jas-
plakinolide caused immediate inhibition of protrusion in
migrating fibroblasts; inhibited lamellipodium protrusion
in non-migrating fibroblasts but with a delay in the onset;
and rapidly reduced the rate of Listeria motility in Ptk2
cells. In each of these three systems, cellular response to
jasplakinolide (Figure 3e; Figure 5a, open symbols;
Figure 6, circles) correlated temporally with inhibition of
actin-filament disassembly but not with promotion of an
increase in actin polymer, a weaker activity of jasplakino-
lide. In the absence of any other known jasplakinolide
activity in cells, this argues strongly that lamellipodium
protrusion and Listeria motility (and, thus, actin-filament
assembly) are coupled to filament disassembly. The data
provide direct evidence for previous arguments in the lit-
erature [4]. In the lamellipodium of migrating fibroblasts
(for example Figure 6, diamonds) and with Listeria motil-
ity in PtK2 cells (Figure 6, circles), the coupling was fast,
suggesting that filament disassembly is rate limiting for
protrusion and Listeria motility in these cell systems. In
contrast, in lamellipodia of non/slowly-migrating fibrob-
lasts the coupling was slower (for example Figure 6,
squares), suggesting a distinct rate-limiting step. How is
this explained? Because detailed characterisation of bio-
chemical properties of jasplakinolide cannot account for
slower coupling, the most likely explanation is a differ-
ence in the actin cycle. A simple theory that I favour is
that fast coupling reflects a preference for disassembling
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Figure 4
Actin-filament staining in jasplakinolide-treated migrating fibroblasts.
Cells were (a) untreated or (b–d) treated live with 1 µM jasplakinolide
for 5, 20 and 61 min, respectively, then fixed, permeabilised and stained
for actin filaments. In (a,b), the lamellipodium is denoted between pairs
of arrowheads; the lamella, behind the lamellipodium, is located between
the short arrows; the cell body and rear, behind the lamella, are located
between the innermost short arrow and the long arrow. In (b), note that
the actin cytoskeleton is not perturbed and the lamellipodium remains
intact. In (c), the lamellipodium has retracted (as expected, see
Figure 3). In 15–30% of cells, small actin filament foci have appeared in
the lamella (short arrow); actin bundles in the cell body remained intact
(long arrow). In (d), the actin cytoskeleton is perturbed; actin filaments
are aggregated (arrow). The scale bar in (c) applies to (a–d).
(a) (c)
(d)
(b)
0 min 20 min
61 min
20 µm
5 min
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filaments as the source of required free monomer for fila-
ment assembly (Figure 7a, fast-coupled model). Con-
versely, in slow coupling, stored monomer is the preferred
source (Figure 7b, slow-coupled model); in this model, fil-
ament disassembly instead refuels stored monomer. This
is consistent with the initial 10 minute lag in inhibition of
protrusion when disassembly is blocked with jasplakino-
lide in non-migrating cells (stored monomer is depleted),
followed by a decrease in the rate of protrusion (depleted
stores are not replaced). These simple scenarios invoke a
direct role for monomer desequestration in slow coupling,
but not fast coupling. 
A more complex theory is that the buffering capacity
(balance between sequestration and desequestration)
thought to exist for certain sequestering proteins [29] is
coupled to filament disassembly in both fast coupling and
slow coupling. In fast coupling, free monomer made avail-
able by filament disassembly is immediately sequestered,
rapidly promoting desequestration elsewhere in the
lamellipodium. In slow coupling, buffering must be
leaky or less rapidly coupled to filament disassembly.
Another interpretation of the data is that blocking
disassembly inhibits feedback regulatory systems required
for protrusion. This imposes differential regulation of pro-
trusion in migrating and non-migrating fibroblasts. Dis-
tinguishing between these models will require direct
observation of the origin and fate of free monomer in live
cells as it becomes available in the lamellipodium, an
investigation beyond the scope of this study. Whether
the situation in migrating and non-migrating fibroblasts
reflects the situation for migrating and non-migrating cell
types in general remains to be tested. One possibility is
that the mechanism in any given cell type is instead
determined by the relative concentrations of actin fila-
ments and actin monomer, for example.
Although fast-coupling occurs for both protrusion in migrat-
ing fibroblasts and Listeria motility, there is a subtle differ-
ence between the two motile cell systems. This is that it
takes a relatively long time to completely inhibit all Listeria
motility (Figure 6, compare circles and diamonds). This is
difficult to interpret without further experimentation. One
intriguing possibility is explained by location-dependent
accessibility of actin monomer. The bulk of Listeria move
in the cell body and lamella of cells and, in these locations
in PtK2 cells, there is a sizeable pool of actin monomer
(unpublished observations). Listeria may also be capable of
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20 µm 6.5 µm
Jasplakinolide treatment of non-migrating fibroblasts. Live non-
migrating fibroblasts were treated with 1 µM jasplakinolide and
(a) imaged every minute by phase contrast time-lapse microscopy, or
(b–f) pretreated live then fixed, permeabilised and stained for actin
filaments. (a) History of lamellipodium protrusion (filled symbols) and
lamellipodium length (in the direction of protrusion, open symbols) for
three non-migrating live cells. (b) Lamellipodium length distribution in
fixed cells. In each case, 154 measurements of 48–52 lamellipodia
were made in 25–26 cells. The average length was 1.1 ± 0.04 µm for
untreated cells, 5.1 ± 0.13 µm and 7.3 ± 0.22 µm for cells treated with
jasplakinolide for 10 min and 20 min, respectively. (c) Untreated cell.
(d,e) Cells treated with 1 µM jasplakinolide for (d) 20 min or (e) 61 min.
Examples of lamellipodia are indicated between pairs of arrowheads in
(c,d) or pairs of lines in (f). In (d), the actin cytoskeleton is not
perturbed and lamellipodia remain intact; in some cells, lamellipodium
retraction began to occur around 20 min (see (a); filled symbols). In
(e), the actin cytoskeleton is perturbed; actin filaments are aggregated
(arrow). (f) The upper and lower images are twofold magnifications of
lamellipodia shown in (c,d), respectively. The lower image has been
rotated roughly 30° clockwise for comparison with the upper image.
Note apparent accumulation of actin filaments at the back of the
lamellipodium in the treated cell (arrows). The scale bar in (e) applies
to (c–e). The scale bar in (f) applies to (f).
consuming this monomer pool during motility. Previous
work in cell extracts has suggested an important role for
actin-depolymerising factor (ADF)/cofilin in disassembly
of actin filaments in Listeria tails [30,31]. Here, the data on
jasplakinolide effects in intact cells reveal significant
dependence on filament disassembly for Listeria motility.
Why actin-filament disassembly is more important for pro-
trusion in certain cell systems, and how cells harness disas-
sembling filaments for motility is unknown. That this
occurs in cells reveals an interesting and previously
unrecognised aspect of actin-assembly dynamics. It may
turn out that the importance of filament disassembly for
motility in an individual cell type is dependent on
monomer availability and cell activity. Stored actin
monomer allows a large stockpile of monomer to accumu-
late in an inactive cell. This is ideal for responding rapidly
to an initial signal that initiates motility by freeing
monomer for the first round(s) of assembly. This is the sit-
uation when cell protrusion is initially activated in resting
platelets [32], leucocytes [33] and thyone sperm [34,35].
For an already active cell (such as a migrating fibroblast),
ongoing lamellipodium protrusion might instead be main-
tained by cycles of assembly and disassembly.
Conclusions
Jasplakinolide joins the growing list of small-molecule
inhibitors of the actin cytoskeleton. When used in the
short term in cells, it is a useful tool to study actin-filament
disassembly, without perturbation of cellular actin organi-
sation. Longer-term treatment promotes appearance of fil-
ament aggregates, and gross disruption to actin
organisation. The precise time that this occurs shortens
with increasing jasplakinolide concentration, and the drug
should be titrated in any given cell system of interest. This
study reveals rapid coupling between actin-filament disas-
sembly and protrusion motility. Whether this implicates an
important role for filament disassembly in supplying the
lamellipodium with a direct source of free actin monomer
remains to be tested. This will not be established until
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Figure 6
Comparison of lamellipodia protrusion and Listeria motility in
jasplakinolide. Migrating and non-migrating fibroblasts, and PtK2 cells
infected with Listeria, were treated with 1 µM jasplakinolide. Absolute
rates of motility were measured for individual live cells for each cell
system, then the population average calculated (Table 1) and
expressed as a percentage of the control (time = 0 min). For
lamellipodium protrusion, rates were calculated between each
successive time interval plotted on the graph; the control was
determined by measuring protrusion over the preceding 5–10 min
before addition of jasplakinolide. For Listeria motility, rates were
determined over 30–60 sec at the indicated times in jasplakinolide.
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Coupling between actin-filament disassembly and protrusion of the
lamellipodium. In theory, there are two extreme roles for actin-filament
disassembly during protrusion of the lamellipodium. In both, protrusion
is tightly coupled to actin-filament assembly, but the rate of protrusion
is limited by filament disassembly in the (a) fast-coupled, but not the
(b) slow-coupled model. (a) Fast-coupled model. Disassembly directly
provides free monomers (black circles) needed for incorporation into
filaments at the leading cell margin. No direct evidence exists for such
a mechanism, but the rate of filament disassembly is fast enough to
account for known rates of protrusion [4]. (b) Slow-coupled model.
Disassembly simply refuels (black circle in bracket) stored monomer
(grey circles in brackets). Protrusion requires release of monomer from
these stores (grey circle freed from bracket). There is some evidence
for this mechanism in the literature [32–34].
(a)
(b)
Current Biology   
spatial and temporal differences in control of actin
monomer and filament pools are examined. In the long
term, these analyses will contribute to the understanding
of the mechanism of protrusion, cell migration and Listeria
motility. That filament disassembly is rate limiting for pro-
trusion of the lamellipodium in migrating chick fibroblasts
means that regulation of filament disassembly is critical for
protrusion in this migrating cell type.
Materials and methods
Preparation of primary chick fibroblasts, and PtK2 cell culture
To obtain individual migrating fibroblasts, explant heart tissue from
6–7 day old chick embryos was gently pipetted under media onto glass
coverslips coated with matrigel (Becton Dickson) and poly-L-lysine
(Sigma). Under these conditions, there is first a lag phase (12–24 h)
during which the explant attaches to the matrigel/poly-L-lysine and cells
migrate to the boundary of the explant itself. The first fibroblasts to
reach the boundary of the explant were used for experiments within
0–12 h (12–36 h total from plating the explant). These are a population
of rapidly migrating fibroblasts with characteristic polarised morphology
and speed of migration (0.5–1.5 µm/min). The variation in the lag
phase was recently discovered and varies with batch of matrigel from
the supplier. The lag time makes no difference to the behaviour of cells
(in terms of polarised morphology, organisation of the actin cytoskele-
ton, behaviour in jasplakinolide) once they have cleared the boundary of
the explant. Non-migrating or slowly migrating chick heart fibroblasts
were prepared as above, but cultured for 4–8 days. It has long been
recognised that primary fibroblasts lose their characteristic polarised
morphology and ability to migrate rapidly with longer time in culture
[36]. For the filament-assembly test (Figure 2), a mixed population of
migrating and non-migrating fibroblasts on the same individual cover-
slip was prepared by culturing cells from the same explant preparation
for 2–3 days. PtK2 cells were grown [28] and infected with L. monocy-
togenes [37] essentially as described. In general and particularly for
the actin-disassembly test (Figure 1), PtK2 cells were cultured at lower
density to promote growth as individual cells or cells in islands with
lamellipodia. When cultured at higher density, PtK2 cells grow in
monolayers or sheets and do not generally protrude lamellipodia.
Drug treatment of cells
Live cells were treated with 1 µM jasplakinolide or 5 µM latrunculin-A,
made-up in warm media immediately before use from a frozen
500–1000 × DMSO stock. Final DMSO added to cells was 0.1–0.2%,
which alone has no effect on cell behaviour or organisation of the actin
cytoskeleton (data not shown). For time-lapse experiments on fibro-
blasts and cell respreading after mitosis in PtK2 cells, jasplakinolide
was added to cells directly on the microscope after the pre-treatment
sequence was recorded, without stopping the time-lapse acquisition.
For cell respreading after mitosis, jasplakinolide was added towards
the beginning of respreading. This allowed maximal treatment with jas-
plakinolide before cells reached the end of respreading. For experi-
ments on PtK2 cells infected with Listeria, cells were time-lapsed by
Lisa Belmont (University of California, Berkeley) at periodic intervals
before and during treatment with 1 µM jasplakinolide.
Cell staining
Unless stated otherwise, cells were stained for actin filaments with
Alexa594–phalloidin (Molecular Probes) at 0.25–1 µg/ml. In brief, cells
were fixed in 4% formaldehyde in cytoskeleton buffer, permeabilised in
0.5% Triton-X-100, and blocked in 2% BSA, using a method that opti-
mally preserves the actin cytoskeleton [24]. For the filament-disassem-
bly test (Figure 1), live cells were permeabilised in cytoskeleton buffer
plus 0.1% Triton-X-100. For incorporation of exogenous actin in live
permeabilised cells (Figure 2), the method of Symons and Mitchison
[23] was followed, except live cells were permeabilised with 0.4 mg/ml
saponin for 10 min in the presence of Alexa488–rabbit skeletal muscle
actin monomer (Molecular Probes).
To measure cellular actin polymer, cells were fixed for 45–60 sec in
–20°C methanol, after pretreating them live for 0, 5, 20 and 60 min
with 1 µM jasplakinolide. Actin filaments were then visualised by indi-
rect immunofluorescence, using a monoclonal anti-peptide antibody to
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Table 1
Effect of 1 µM jasplakinolide on actin-based cell motility.
Type of cell motility Average rate of motility* Inhibition of motility 
Before treatment Jasplakinolide treatment Jasplakinolide treatment (min†)
(3 min) (10 min)
Lamellipodium protrusion 0.89 ± 0.06 (n = 20) 0.24 ± 0.03 (n = 20) NA 1‡–5
(migrating fibroblasts)
Listeria motility 10.1 ± 0.6 (n = 30) 4.32 ± 0.5 (n = 28) 2.65 ± 0.6 (n = 16) 3‡–15
(in PtK2 cells)
Lamellipodium protrusion 0.87 ± 0.04 (n = 22) ND 0.75 ± 0.04 (n = 22) 12–20
(non-migrating fibroblasts)
Cell-body translocation 0.81 ± 0.06 (n = 17) ND 0.79 ± 0.05 (n = 17) Not inhibited
(migrating fibroblasts)
Cell respreading 1.08 ± 0.13 (n = 10) ND 0.98 ± 0.08 (n = 10) Not inhibited
after mitosis (PtK2 cells)
*For lamellipodium protrusion, cell-body translocation and cell
respreading after mitosis, rates (µm/min) were determined over the
total time indicated in jasplakinolide and typically over 5–10 min before
treatment. Over this time interval before treatment, motility is generally
continuous and thus rates, when compared, are not overestimated or
underestimated. For Listeria, which move at much higher rates and
typically the same bacterium can be identified and tracked in the cell
for around 1 min, rates were measured over 30–60 sec before
treatment and over 30–60 sec at each specified total time in
jasplakinolide. NA, not applicable; ND, not determined. †For fibroblasts
this is for individual cells, for Listeria this is the range over which
motility rate is reduced; it is not possible to track individual Listeria
over the entire course of drug treatment. ‡ This is the earliest time in
drug treatment that the cells were imaged by timelapse microscopy. 
actin (Sigma). Only actin filaments are stained under the methanol fixa-
tion conditions for this antibody. Brief methanol fixation results in good
preservation of the actin cytoskeleton.
Image acquisition
For time-lapse microscopy, cells were transferred on the day of the
experiment to a custom-made aluminium chamber heated by a circulating
waterbath set at 37°C (final temperature in the media in the chamber was
around 34°C). Time-lapse microscopy of live cells and taking still images
of fixed and stained cells were performed using a cooled charge-coupled
device camera (KAF 1400, Princeton Instruments) on an Axiovert micro-
scope (Zeiss) controlled by Metamorph software (Universal Imaging). 
Image processing, lamellipodium length measurement and
fluorescence quantitation
Images were digitally captured and processed. Merged images
(Figure 2e,f), the kymograph (Figure 3d), lamellipodium measurements,
and fluorescence quantitation were done with Metamorph software
(Universal Imaging). The camera has a small pixel size (6.9 µm), large
pixel array (1317 × 1075), and is 12-bit with > 99.9% linearity. This
enabled high-resolution images of lamellipodia and highly sensitive fluo-
rescence detection. So that a large sample size could be obtained in a
reasonable time, lamellipodium length was measured mainly from fixed
cells, stained for actin filaments, captured with a 63 ×, 1.4 NA oil objec-
tive. Lengths were also independently measured from phase-contrast
images of live cells captured with a 40 ×, 0.75 NA dry objective, and
gave the same results. In both cases, individual images were enlarged
200–400% on screen to allow accurate measurement with the Meta-
morph line-measuring tool. The lamellipodium was readily identified in
the cell especially at the high resolution used for measurements. By
F-actin staining, the lamellipodium is an intense band, clearly distin-
guished from the lamella (situated behind the lamellipodium), which is
relatively dim. By phase contrast, the boundary between the lamel-
lipodium and lamella is clearly defined; the lamellipodium is thinner, and
the lamella is more phase dense and granular in appearance. 
For fluorescence quantitation, staining conditions, the microscope
objective (63 ×, 1.4 NA oil) and camera exposures in any given cell
system and when comparing cell regions in migrating and non-migrat-
ing fibroblasts, were the same. All measurements were made on
unprocessed images. Background fluorescence was subtracted from
all measurements. In each individual cell or cell region, total fluores-
cence (sum of all grey levels) was measured. So that cells or cell
regions of different sizes could be compared, total fluorescence was
normalised to total area. The population average was then calculated.
For measuring cellular actin polymer in jasplakinolide, the relative per-
centage increase in fluorescence (comparing before and after treat-
ment) was then determined.
Supplementary material
Movies are available at http://current-biology.com/supmat/supmatin.htm.
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